OVERVIEW
BioValuate AI is a SaaS platform that leverages real-time data, machine learning, and biotech-specific financial modeling to provide dynamic company valuations. It’s designed to support M&A, investment decisions, IPO readiness, and internal strategic planning.
KEY FEATURES
1. Real-Time Valuation Engine
Uses AI to calculate pre-money/post-money valuations
Factors: pipeline stage, IP strength, trial progression, market comps, revenue potential, and burn rate.
2. IP & Asset Value Estimator
Scans patent databases and licensing activity to assess IP strength and potential royalty/revenue streams.
3. Comparable Company Analysis
Pulls data from public/private biotech firms
Allows filtering by indication, modality (e.g., mRNA, cell therapy), region, and phase.
4. Milestone & Risk Adjusted Forecasting
Projects value inflections based on trial success probabilities, regulatory timelines, and strategic events
5. Due Diligence-Ready Reports
Auto-generates pitch decks, investor memos, and M&A-ready valuation reports.
6. Integration Suite
Connects with CRMs (e.g., Salesforce), databases (e.g., PitchBook, PubMed), and internal trial trackers.
7. AI-Driven Alerts
Notifies users of valuation-impacting events like competitor approvals, patent expirations, or trial results.
CLIENTS
Biotech Founders & CFOs – For internal valuation and fundraising strategy
VC & PE Firms – For evaluating deal flow and portfolio performance
Pharma Corporate Dev Teams – For M&A targeting and licensing strategy
Investment Banks – For IPO readiness and roadshows
Regulatory & Legal Consultants – For risk profiling and audit support
24+
PRIVATE PROJECTS
3
TIERED SUBSCRIPTION PRICING MODELS
TIER 0NE
Starter
1 user, basic valuation tools,
2 assets
$799/month
TIER TWO
Pro
5 users, full features,
10 assets
$2,500/month
TIER THREE
Enterprise
Unlimited users/assets, white-glove support, API access
Custom pricing (starting ~$10K/month)
Contact us
We'd love to hear from you! Whether you have questions about services provided by BioValuate AI, need support, or want to explore partnership opportunities—our team is here to help.
Email: KING.QUONFREDRICK@APEXAIAGENCY.ORG
King Quonfredrick Terell Meeks
Founder / CEO
Mark Edward Moore Jr.
Founder / CFO
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.